Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutations in ERBB3 drive tumorigenesis.

Cancer discovery - 1 Jul 2013

Abstract excerpt

Somatic ERBB3 hot-spot mutations promote oncogenic signaling in a subset of human tumors.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Carcinogenesis
Share to Cell Line, Tumor
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Receptor, ErbB-2

Share to Receptor, ErbB-3

Share to Signal Transduction

Share to Xenograft Model Antitumor Assays

Source

Identifiers

PMID: 23847370
DOI: 10.1158/2159-8290.CD-RW2013-107

Genes

ERBB3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutations in ERBB3 drive tumorigenesis.PMID 23847370Read ↗

Trans-activating mutations of the pseudokinase ERBB3.Semantic proximity Read ↗

HER3 Comes of Age: New Insights into Its Functions and Role in Signaling, Tumor Biology, and Cancer TherapySemantic proximity Read ↗

Oncogenic ERBB3 mutations in human cancers.Semantic proximity Read ↗

Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid Tumors.Semantic proximity Read ↗

Trans-activating mutations of the pseudokinase ERBB3Semantic proximity Read ↗

An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations.Semantic proximity Read ↗

Genomic alterations of ERBB receptors in cancer: clinical implicationsSemantic proximity Read ↗

Activating HER3 mutations in breast cancerSemantic proximity Read ↗

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies.Semantic proximity Read ↗

IKZF3 amplification frequently occurs in HER2-positive breast cancer and is a potential therapeutic target.Semantic proximity Read ↗

Regulation of ERBB3/HER3 signaling in cancer.Semantic proximity Read ↗

Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.